|
2311 |
Introduction and validation of the open symptom framework: a public domain modular framework for patient-reported measurement of symptoms related to cancer and its treatment Enthalten in Quality of life research Bd. 33, 18.7.2024, Nr. 9, date:9.2024: 2349-2358
|
|
|
2312 |
Introduction for the First Issue Enthalten in Vocations and learning Bd. 1, 9.1.2008, Nr. 1, date:3.2008: 7-10
|
|
|
2313 |
Introduction for the follow-up of the Eighth International Kraepelin Symposium at LMU Munich Enthalten in European archives of psychiatry and clinical neuroscience Bd. 273, 18.5.2023, Nr. 4, date:6.2023: 761-763
|
|
|
2314 |
Introduction from the Editors Enthalten in Allergy, asthma and clinical immunology Bd. 14, 12.9.2018, Nr. 2, date:9.2018: 1-3
|
|
|
2315 |
Introduction from the editors Enthalten in Allergy, asthma and clinical immunology Bd. 20, 13.1.2025, Nr. 3, date:12.2024: 1-4
|
|
|
2316 |
Introduction into PPPM as a new paradigm of public health service: an integrative view Enthalten in European Association for Predictive, Preventive and Personalised Medicine: The EPMA journal Bd. 3, 9.11.2012, Nr. 1, date:12.2012: 1-11
|
|
|
2317 |
Introduction of 3D-classification and its derived surgical sequence of Schatzker type IV tibial plateau fractures Enthalten in BMC surgery Bd. 23, 9.12.2023, Nr. 1, date:12.2023: 1-16
|
|
|
2318 |
Introduction of a 3D-organotypic co-culture model for head and neck squamous cell carcinoma Enthalten in Laryngo-Rhino-Otologie Bd. 98, 2019, Nr. S 02, 02
|
|
|
2319 |
Introduction of a 6-cyano group in 14-oxygenated N-methylmorphinans influences in vitro and in vivo pharmacological activities Enthalten in BMC pharmacology Bd. 11, 5.9.2011, Nr. 2, date:12.2011: 1-2
|
|
|
2320 |
Introduction of a breast apparent diffusion coefficient category system (ADC-B) derived from a large multicenter MRI database Enthalten in European radiology Bd. 33, 11.5.2023, Nr. 8, date:8.2023: 5400-5410
|
|